Paytm may still hit ₹2,300, Nomura says despite MDR concerns
In short
Paytm shares were seen as able to reach ₹2,300 levels despite concerns over MDR. CNBC TV18 Market said 24 analysts cover the stock, with 20 buy ratings and four hold ratings.
The ratings suggest market support for the stock, and the consensus target points to about 16% upside from current prices.
What the reporting says
Paytm share price was said to still have room to test ₹2,300 levels, even as MDR uncertainty remained a concern. CNBC TV18 Market reported that 20 of the 24 analysts covering Paytm have a buy rating, four have hold ratings, and none have sell ratings. The consensus price targets point to about 16% upside from current levels.
Why it matters
Paytm was highlighted by analysts as having potential upside even with MDR uncertainty in the background. The coverage data showed strong analyst support, with no sell ratings among the 24 analysts tracked. The consensus target implies further gains from current levels, which keeps the stock in focus for investors watching payment-sector policy risk.